Tuesday, 12 May 2020

India's Jubilant Signs Licensing Deal For US Pharma Firm's COVID-19 Drug

India's Jubilant Life Sciences Ltd said on Tuesday it had signed a non-exclusive licensing agreement for selling Gilead Sciences Inc's experimental COVID-19 treatment remdesivir in 127 countries,...

from NDTV News - Special https://ift.tt/3bqUqQ1
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Waiting For A Promotion? In Chhattisgarh Department, 11 Dead People Got One

Some people spend years waiting for a promotion, doing everything they can to be eligible for one: from working long hours to being extra ni...